| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $1.23M | +1.67K | +5.41% | $737.26 | 32.5K | 12 Feb 2024 | Direct | |
| holding | LLY | Common Stock | 402 | 12 Feb 2024 | 401(k) | ||||||
| holding | LLY | Common Stock | 1.77K | 12 Feb 2024 | 401(k) - by partner | F1 | |||||
| holding | LLY | Common Stock | 128 | 12 Feb 2024 | by partner | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +1.31K | $0.00 | 1.31K | 12 Feb 2024 | Common Stock | 1.31K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |